Attributable cost of methicillin resistance: an issue that is difficult to evaluate

doi:10.1186/cc4994

Critical Care
Volume 10
Issue 4

Viewing options:

Abstract
Full text
PDF (34KB)

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Timsit JF

on PubMed

Timsit JF
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Commentary

Attributable cost of methicillin resistance: an issue that is difficult to evaluate

Jean-François Timsit

Groupe d'épidémiologie des cancers et des affections graves INSERM U 578, Service de réanimation médicale, University Hospital Albert Michallon, 38043 Grenoble Cedex, France

author email corresponding author email

Critical Care 2006, 10:157doi:10.1186/cc4994


Published:	11 August 2006

See related research by Shorr et al.: http://ccforum.com/content/10/3/R97

Abstract

Estimating the consequences and the cost of methicillin resistance is a difficult challenge. Patients who develop methicillin-resistant ventilator-associated pneumonia (VAP) are very different from those who develop methicillin-sensitive VAP, and biased estimates are frequent. We reviewed some important confounding factors of which the reader should be aware.